Clinical Trials
2 trialsNCT04731740 2024-03-25
Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer
Saint Petersburg State University, Russia
Phase 2 Withdrawn
NCT01747512 2017-11-14
An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
AHS Cancer Control Alberta
Phase 2 Withdrawn